Today’s top gainers include the company Abbott Laboratories (NYSE:ABT) which is in the industry Medical Appliances & Equipment, gaining 0.44% today. In the last week its performance is 2.54%, and -1.46% for the past quarter. Currently, Abbott Laboratories, ABT has a target price of 47.64, so today’s gain of 0.44% is a significant step towards its target price. The GAP today is therefore -0.21%.
Abbott Laboratories (NYSE:ABT), has a market cap of 63232.39, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 71.10%.
At the current price of 43.36, it has a dividend yield of 2.41%, and its target price is 47.64. This is with a profit margin of 11.10%, and total debt/equity of *TBA. Abbott Laboratories (NYSE:ABT) has a P/E of 33.13, as well as a forward P/E of 17.59.
With a current EPS of 1.3, and a forecasted EPS growth for next year at 11.60%,Abbott Laboratories (NYSE:ABT) has had a EPS growth for the past five years at -10.30%. For the next five years EPS growth is projected to be 9.31%.
Performance for the year is -13.61%. Since its IPO date on 4/6/1983, the total performance to date is -2.08%.
Volume today for Abbott Laboratories (NYSE:ABT), is 4967419, while its average volume is 11535.37. Whilst the total gain today was 0.44%, it did have a day high of -0.14%.
Volatility for this week has been at 1.27%, and 1.58% for the month. The 52-week low for Abbott Laboratories, ABT has been 21.93%, while the 52-week-high has reached -14.13%.
Looking at its return of investments, which is 7.70%, and its return on assets is *TBA. Abbott Laboratories (NYSE:ABT) has an operating margin of 14.00%. With a sales growth of 3.20% quarter over quarter. Bearing in mind that Abbott Laboratories, ABT is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of Abbott Laboratories? Well its PEG is 3.56, and the P/S is 3.08, along with a P/B of 3.06. Meanwhile it has a p/cash of *TBA.